GSK polio vaccine to launch in July.

GSK took the KFDA approval for the market release of Poliorix, an anti-poliomyelitis vaccine, which is an injectable inactivated poliovirus vaccine containing 1, 2 and 3 type of polio virus. It is administered for the baby of two month old 3 times with 4 to 8 weeks intervals via intramuscular injection with 0.5ml dose, and the same injection should be boosted at age 4 to 6 years old.

The KCD...